B of A Securities Rates UnitedHealth (UNH) buy, $475 Price Target

B of A Securities maintains a buy rating for UnitedHealth Group, increasing the price target to $475, a 11.01% upside from the current price.

By EarningsIQ Research Desk · Published Jun 24, 2026, 2:02 PM EDT · Updated Jun 29, 2026, 8:03 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

B of A Securities rated UnitedHealth Group Incorporated ($UNH) "buy" with a $475 price target on June 24, 2026.

Since the rating, $UNH is up 5.1% after 1 week, up 3.7% after 1 month and down 0.5% to date (from the $403.32 close on Jun 24, 2026).

UNH UnitedHealth Group Incorporated

$401.43 +21.69% year to date

Daily close · Oct 16, 2026

Key Points

B of A Securities reiterated its buy rating on UnitedHealth Group, raising the price target from an unspecified prior level to $475.
B of A Securities's $475 price target implies 11.01% upside from UnitedHealth Group Incorporated's ($UNH) current $427.89 share price.
Currently trading at $427.89, UnitedHealth's shares have seen a rise from a previous close of $395.62.
Analysts have a consensus buy rating for UnitedHealth, with a mean price target of $477.04 based on 25 opinions.

Get $UNH trade alerts by text

We text you when insiders, Congress or big funds trade $UNH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures

B of A Securities reiterated its buy rating on UnitedHealth Group Incorporated (NYSE: UNH) on June 24, 2026. The firm raised its price target to $475. The stock was trading at $427.89 at the time of the report, up from its previous close of $395.62.

Analyst rating track record

B of A Securities vs. the S&P 500

YTD return +3.12% hypothetical

All-time return +26.28% S&P 500 +24.26%

vs. S&P 500 +2.02% ahead of the index

Hypothetical returns from B of A Securities's disclosed trades, not real profit or advice. How we model this.

B of A Securities' Call on UnitedHealth Group

Kevin Fischbeck at B of A Securities expressed continued confidence in UnitedHealth Group by reaffirming a buy rating and increasing the price target to $475. This reflects a positive outlook for the company's future performance in the healthcare sector.

Other Institutional Activity in UnitedHealth Group

Several other institutional investors also hold stakes in UnitedHealth. Blackrock Inc. holds 76,863,061 shares valued at about $30.9 billion after increasing its holdings by 3,394,259 shares, a 4.6% rise. Vanguard Capital Management LLC has 59,311,525 shares worth around $23.8 billion, having added 441,525 shares, up 0.8%. State Street Corporation owns 45,633,267 shares valued at approximately $18.3 billion, rising by 299,205 shares, a 0.7% increase. Capital World Investors increased its stake by 2,103,297 shares, totaling 29,887,932 shares worth about $12.0 billion, a 7.6% increase. FMR, LLC has 27,992,995 shares, valued around $11.3 billion, after a significant increase of 15,974,192 shares, a 132.9% jump.

UnitedHealth Group Incorporated Stock Up 8.2%

UnitedHealth is currently trading at $427.89, which is significantly above its 52-week low of $255.97 and close to its 52-week high of $461.62. This positions the stock well within a range that suggests strong performance potential.

12-month forecast

$UNH price target

UnitedHealth Group Incorporated daily closes and this analyst's $475 target. Not advice.

Recent Earnings

In its most recent financial report, UnitedHealth reported a revenue of $450.1 billion but experienced a slight revenue decline. The earnings per share (EPS) came in at $15.55 with a net margin of 3.53%. The next earnings report is scheduled for January 26, 2027.

Insider Buying and Selling at UnitedHealth Group Incorporated

Recent insider activity includes sales by Patrick Hugh Conway, an officer at the company. On August 21, 2026, he sold 1,169 shares at an average price of $390.00, totaling approximately $455,910. Earlier, on August 5, 2026, he sold 500 shares at $410.00 for around $205,000. This selling was not carried out under a planned trading arrangement.

Analysts Set New Price Targets

On October 16, 2026, Bernstein maintained its Outperform rating on UnitedHealth with a price target of $500, down from $512. JP Morgan also maintained its Overweight rating, raising the target from $516 to $524. Additionally, TD Cowen reiterated its Hold rating with a target of $402.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a health care company, offering various services through segments like Optum and UnitedHealthcare. The firm provides care delivery, management, and wellness services to a broad array of clients, including patients and public-sector entities. B of A's rating reflects confidence in its diverse operations and market position.

Bottom Line

Investors should keep an eye on UnitedHealth's upcoming earnings report on January 26, 2027. The reaffirmation of the buy rating by B of A Securities, along with the backstory from other analysts, illustrates the company's stable position in the market. It's important to remember that the 13F filings, like the one from B of A, reflect holdings as of the reporting period and may not represent the current positions of the investors.